Labverity
Facility profile

Navinta LLC

Testing & analysis · Active pharmaceutical ingredient (API) manufacturing · Ewing, NJ

FDA recordFDA directory updated Jul 22, 2026Profile not yet claimed
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

AnalysisActive pharmaceutical ingredient (API) manufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 22, 2026

Latest matched inspection
No action indicated (NAI)

Sep 30, 2024 · No conditions warranted FDA action in this inspection.

Matched compliance actions
Past action on file · 2016

More than five years old · review later records.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched no action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Confirm the inspection scope and whether it covered the work you need.

Method and source details
View full inspection and compliance history6 inspection records

FDA inspection history

6 records, Aug 2015 – Sep 2024 · 3 NAI · 2 VAI · 1 OAI

DateClassProject areaCitationsFY
Sep 30, 2024NAIDrug Quality Assurance2024
May 4, 2023NAIBioresearch Monitoring2023
Mar 28, 2019VAIBioresearch MonitoringYes2019
Aug 18, 2017VAIPostmarket Surv. and EpidemiologyYes2017
May 16, 2016OAIBioresearch MonitoringYes2016
Aug 10, 2015NAIDrug Quality Assurance2015

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

Sep 26, 2016Warning Letter · CDER
Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services